P. Vermylen
Publications by Year
Research Areas
Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Amyotrophic Lateral Sclerosis Research
Most-Cited Works
- → Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration(2001)1,009 cited
- → A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis(2000)268 cited
- → Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma(1999)104 cited
- → Maintenance chemotherapy for small cell lung cancer: a critical review of the literature(1998)92 cited
- Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.(2000)
- Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.(2000)
- → Disseminated angiosarcoma presenting as a hemophagocytic syndrome in a renal allograft recipient(1997)20 cited
- [Critical review of the randomized trials assessing the role of adjuvant thoracic irradiation and chemotherapy in the treatment of limited-stage small cell lung cancer].(1998)
- → Best Supportive Care or Chemotherapy for Stage IV Non-Small Cell Lung Cancer(1999)17 cited
- → A meta-analysis of the role of etoposide (VP16) and cisplatin (CDDP) in small cell lung cancer (SCLC) with a methodology assessment(1999)11 cited